nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—Ephedrine—ADRB2—chronic obstructive pulmonary disease	0.00941	0.205	CrCbGaD
Etomidate—Pseudoephedrine—TNF—chronic obstructive pulmonary disease	0.00805	0.175	CrCbGaD
Etomidate—Pseudoephedrine—ADRB2—chronic obstructive pulmonary disease	0.00713	0.155	CrCbGaD
Etomidate—Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.00671	0.146	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A4—chronic obstructive pulmonary disease	0.00648	0.141	CrCbGaD
Etomidate—ADRA2B—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00554	0.00581	CbGpPWpGaD
Etomidate—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00543	0.00569	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00542	0.00568	CbGpPWpGaD
Etomidate—CYP11B2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00529	0.00555	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.00522	0.00548	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0048	0.00503	CbGpPWpGaD
Etomidate—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.00467	0.102	CrCbGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00466	0.00488	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00465	0.00488	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.0046	0.00482	CbGpPWpGaD
Etomidate—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00456	0.00478	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00449	0.0047	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00439	0.0046	CbGpPWpGaD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00439	0.0046	CbGpPWpGaD
Etomidate—ADRA2B—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00433	0.00454	CbGpPWpGaD
Etomidate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00433	0.00454	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00432	0.00453	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00401	0.0042	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00396	0.00416	CbGpPWpGaD
Etomidate—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00394	0.00413	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00391	0.0041	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00387	0.00405	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00384	0.00402	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00382	0.004	CbGpPWpGaD
Etomidate—ADRA2B—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00364	0.00382	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00361	0.00378	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00358	0.00375	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00356	0.00373	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.00354	0.00372	CbGpPWpGaD
Etomidate—Pethidine—ALB—chronic obstructive pulmonary disease	0.00353	0.0767	CrCbGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00342	0.00358	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.0034	0.00356	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00333	0.00349	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0033	0.00346	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00329	0.00345	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00327	0.00343	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00323	0.00338	CbGpPWpGaD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00319	0.00334	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00318	0.00334	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00316	0.00331	CbGpPWpGaD
Etomidate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00315	0.0033	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00313	0.00328	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00312	0.00328	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00305	0.00319	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00296	0.00311	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00294	0.00308	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00292	0.00306	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00289	0.00302	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00286	0.003	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00282	0.00296	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00281	0.00295	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GC—chronic obstructive pulmonary disease	0.00279	0.00292	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00279	0.00292	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00278	0.00291	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00277	0.00291	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00277	0.0029	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00274	0.00287	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00273	0.00286	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00269	0.00282	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.00263	0.00276	CbGpPWpGaD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00262	0.00275	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.0026	0.00272	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00259	0.00271	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00258	0.00271	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00255	0.00268	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00253	0.00265	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00252	0.00264	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00243	0.00255	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00242	0.00254	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00239	0.0025	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00236	0.00248	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00235	0.00247	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.0023	0.00242	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00227	0.00238	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APIP—chronic obstructive pulmonary disease	0.00226	0.00237	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00225	0.00236	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00225	0.00236	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00222	0.00233	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00221	0.00232	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00213	0.00224	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00206	0.00216	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00195	0.00204	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00189	0.00198	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00186	0.00195	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00186	0.00195	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00184	0.00193	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00181	0.0019	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0018	0.00189	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.00172	0.0018	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00171	0.00179	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00163	0.00171	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00161	0.00169	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.0016	0.00167	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00158	0.00165	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00157	0.00165	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00155	0.00163	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HDAC2—chronic obstructive pulmonary disease	0.00153	0.0016	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00152	0.0016	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.0015	0.00158	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0015	0.00157	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00149	0.00156	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00148	0.00155	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00146	0.00153	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GC—chronic obstructive pulmonary disease	0.00146	0.00153	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00145	0.00152	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00143	0.0015	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KL—chronic obstructive pulmonary disease	0.00142	0.00149	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00139	0.00146	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00137	0.00144	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00137	0.00144	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.00137	0.00143	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00135	0.00142	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00135	0.00142	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00133	0.0014	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00131	0.00137	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00129	0.00135	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00128	0.00134	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00126	0.00133	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GC—chronic obstructive pulmonary disease	0.00126	0.00132	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00117	0.00122	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00111	0.00117	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.0011	0.00116	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.00113	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00107	0.00112	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB3—chronic obstructive pulmonary disease	0.00106	0.00112	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00105	0.00111	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00104	0.00109	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000969	0.00102	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000936	0.000981	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00093	0.000975	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000919	0.000963	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000917	0.000961	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000911	0.000955	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS2—chronic obstructive pulmonary disease	0.000888	0.00093	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000836	0.000877	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000819	0.000859	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000811	0.00085	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000808	0.000847	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000796	0.000834	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000787	0.000825	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000787	0.000825	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00078	0.000818	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000775	0.000813	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000747	0.000783	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000734	0.000769	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000731	0.000767	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000728	0.000763	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000725	0.00076	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000718	0.000753	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000717	0.000751	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000714	0.000748	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—chronic obstructive pulmonary disease	0.000714	0.000748	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000712	0.000746	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000708	0.000743	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000698	0.000732	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000691	0.000724	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000689	0.000722	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000686	0.000719	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000678	0.000711	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00067	0.000703	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000662	0.000693	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000662	0.000693	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000657	0.000688	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000656	0.000688	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000642	0.000673	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000632	0.000663	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000629	0.000659	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000625	0.000655	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000624	0.000654	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000619	0.000649	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000613	0.000643	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000598	0.000626	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000571	0.000599	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00057	0.000598	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000563	0.00059	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000557	0.000584	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000552	0.000579	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000552	0.000578	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000546	0.000572	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000544	0.00057	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000539	0.000565	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000536	0.000562	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000527	0.000552	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000507	0.000531	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000481	0.000504	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000475	0.000498	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000475	0.000498	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—chronic obstructive pulmonary disease	0.000472	0.000495	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000469	0.000492	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000469	0.000491	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—chronic obstructive pulmonary disease	0.000463	0.000485	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.00046	0.000482	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000454	0.000476	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000443	0.000464	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000437	0.000458	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000436	0.000457	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000423	0.000443	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000418	0.000439	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000414	0.000434	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000402	0.000422	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000394	0.000413	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000389	0.000407	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000384	0.000403	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000368	0.000386	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000358	0.000376	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000358	0.000375	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000356	0.000373	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—chronic obstructive pulmonary disease	0.000356	0.000373	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000355	0.000372	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000353	0.000369	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000351	0.000368	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.00034	0.000356	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000337	0.000354	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000337	0.000353	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000327	0.000342	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.000339	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000322	0.000337	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00032	0.000336	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000313	0.000328	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000308	0.000323	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000282	0.000295	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00028	0.000294	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000269	0.000282	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000269	0.000282	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000266	0.000279	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000248	0.00026	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000247	0.000259	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000245	0.000257	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.000246	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000229	0.00024	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000225	0.000236	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000212	0.000222	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000191	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000189	0.000198	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000185	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000173	0.000181	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000172	0.00018	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000165	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.00016	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000154	0.000161	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000153	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000126	0.000133	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000121	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000115	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000102	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.72e-05	0.000102	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.24e-05	9.69e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.3e-05	8.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.62e-05	7.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.47e-05	7.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.27e-05	6.57e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.74e-05	6.02e-05	CbGpPWpGaD
